Eagle Capital Management (New York)
ELV icon

Eagle Capital Management (New York)’s Elevance Health ELV Stock Holding History

Eagle Capital Management (New York)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577M Sell
1,491,409
-57,201
-4% -$21.2M 1.76% 23
2026
Q1 		$453M Buy
1,548,610
+44,559
+3% +$14.6M 1.52% 26
2025
Q4 		$527M Sell
1,504,051
-67,640
-4% -$22.9M 1.64% 23
2025
Q3 		$508M Sell
1,571,691
-3,259
-0.2% -$1.01M 1.62% 22
2025
Q2 		$613M Sell
1,574,950
-10,398
-0.7% -$4.18M 2.02% 21
2025
Q1 		$690M Buy
1,585,348
+20,732
+1% +$8.32M 2.52% 18
2024
Q4 		$577M Sell
1,564,616
-35,614
-2% -$14.9M 2.1% 22
2024
Q3 		$832M Sell
1,600,230
-8,286
-0.5% -$4.43M 3.09% 15
2024
Q2 		$872M Buy
1,608,516
+42,280
+3% +$22.3M 3.23% 14
2024
Q1 		$812M Sell
1,566,236
-44,233
-3% -$22M 3.14% 16
2023
Q4 		$759M Buy
1,610,469
+225,991
+16% +$104M 3.22% 14
2023
Q3 		$603M Buy
1,384,478
+632,511
+84% +$287M 2.79% 14
2023
Q2 		$334M Sell
751,967
-47,826
-6% -$22.1M 1.5% 21
2023
Q1 		$368M Sell
799,793
-72,917
-8% -$34.7M 1.68% 22
2022
Q4 		$448M Sell
872,710
-434,173
-33% -$220M 2.12% 20
2022
Q3 		$594M Sell
1,306,883
-33,360
-2% -$16M 2.7% 18
2022
Q2 		$647M Sell
1,340,243
-1,038,243
-44% -$514M 2.81% 17
2022
Q1 		$1.17B Sell
2,378,486
-79,954
-3% -$36.5M 3.95% 11
2021
Q4 		$1.14B Sell
2,458,440
-88,455
-3% -$37.2M 3.4% 16
2021
Q3 		$949M Sell
2,546,895
-78,913
-3% -$30M 2.79% 17
2021
Q2 		$1B Buy
2,625,808
+404,811
+18% +$155M 2.86% 16
2021
Q1 		$797M Sell
2,220,997
-232,002
-9% -$74.6M 2.46% 18
2020
Q4 		$788M Sell
2,452,999
-130,966
-5% -$40.2M 2.5% 19
2020
Q3 		$694M Buy
2,583,965
+425,188
+20% +$114M 2.49% 17
2020
Q2 		$568M Buy
2,158,777
+909,917
+73% +$243M 2.08% 19
2020
Q1 		$284M Buy
+1,248,860
New +$340M 1.18% 23

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eagle Capital Management (New York)'s ELV Position: Q2 2026 in Review

Eagle Capital Management (New York) reduced its Elevance Health (ELV) stake by 3.7% in Q2 2026, selling an estimated $21.2M and leaving 1,491,409 shares worth $577M. The position accounts for 1.76% of the portfolio, ranked #23.

Eagle Capital Management (New York) first reported a position in ELV in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.17B in Q1 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Eagle Capital Management (New York) held 1,491,409 shares of Elevance Health worth $577M as of Q2 2026.
  • Eagle Capital Management (New York) sold 57,201 Elevance Health shares in Q2 2026, an estimated $21.2M.
  • Elevance Health made up 1.76% of Eagle Capital Management (New York)'s portfolio in Q2 2026, its #23 holding.
  • Eagle Capital Management (New York) first reported a position in Elevance Health in Q1 2020 and has held it in 26 quarters since.
  • Eagle Capital Management (New York)'s Elevance Health position peaked at $1.17B in Q1 2022.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Eagle Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.